C4X Discovery Holdings plc has exclusively licenced its NRF2 Activator programme to AstraZeneca and has got an...
Up To Date
Latest News
Munich-based immunooncology specialist CatalYm GmbH wants to use €50m from a Series C financing round to...
Cellular agriculture company Cultimate Foods UG has got a pre-seed funding led by Big Idea Ventures, ProVeg...
Biotech start-up Cradle BV has raised €5.4m in seed financing to design cell-factories with AI and scale...
Microbial casein maker Standing Ovation SA has inked an exklusive collaboration with Bel Group, one of...
EpiEndo Pharmaceuticals ehf got the green light for a Phase IIa COPD trial with its non-anbibiotic macrolide...